Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side ef...
Saved in:
Main Authors: | Massimo Montalto, Italo Porto, Antonella Gallo, Claudia Camaioni, Roberta Della Bona, Antonio Grieco, Filippo Crea, Raffaele Landolfi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Vascular Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/867964 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01) -
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial
by: Mohammadjavad Mehdizadeh Parizi, et al.
Published: (2023-01-01) -
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
by: Bartosz Olechowski, et al.
Published: (2016-01-01) -
Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
by: Heiko Koerner, et al.
Published: (2012-01-01) -
Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
by: Karem H. Alzoubi, et al.
Published: (2025-06-01)